Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about SRPT
Recent news which mentions SRPT
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
2 Under-the-Radar Biotech Stocks to Buy in 2022
October 19, 2022
Tickers
CRSP
SRPT
Tags
SRPT
CRSP
Market News
From
Motley Fool
Apple To $177? Plus This Analyst Slashes PT On Opendoor Technologies By About 71%
October 17, 2022
Tickers
AAPL
BILL
LIN
OPEN
Tags
Penny Stocks
Trading Ideas
Pre/Market Outlook
From
Benzinga
7 Analysts Have This to Say About Sarepta Therapeutics
October 13, 2022
Tickers
SRPT
Tags
SRPT
Analyst Ratings
BZI/AAR
From
Benzinga
PepGen's Duchenne Candidate Has Potential For Greater Exon Skipping Capabilities At Lower Doses Versus Sarepta's Candidate, Says Analyst
September 28, 2022
Tickers
PEPG
SRPT
Tags
Health Care
Reiteration
Trading Ideas
From
Benzinga
$6 Million Bet On Sarepta Therapeutics? 3 Stocks Insiders Are Buying
September 16, 2022
Tickers
CNA
COIN
SRPT
Tags
Insider Buying
Long Ideas
Benzinga
From
Benzinga
Analyst Ratings for Sarepta Therapeutics
September 08, 2022
Tickers
SRPT
Tags
Analyst Ratings
SRPT
BZI/AAR
From
Benzinga
A Biotech's Stock Just Hit Year High. This Analyst Expects It To Jump Another 16%
September 08, 2022
Tickers
SRPT
Tags
Briefs
Price Target
Benzinga
From
Benzinga
FDA Lifts Clinical Hold On Sarepta's Dose-Expansion Part Of Duchenne Trial
September 06, 2022
Tickers
SRPT
Tags
Briefs
News
Health Care
From
Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
August 29, 2022
Tickers
CRSP
MYGN
SRPT
Tags
Market News
Recent Press Releases
CRSP
From
Motley Fool
Sarepta In-Licenses Next-Gen AAV Tech Covering Five Indications
August 08, 2022
Tickers
SRPT
Tags
General
Briefs
Biotech
From
Benzinga
Is Biotech Back? This Analyst Sees 18% Upside Potential In This Bio Play
August 08, 2022
Tickers
SRPT
Tags
SRPT
Analyst Ratings
Market News
From
Benzinga
Sarepta's Duchenne Gene Therapy Update Gets Bullish Stance From Analysts
August 03, 2022
Tickers
SRPT
Tags
News
Price Target
Briefs
From
Benzinga
Sarepta Therapeutics (SRPT) Q2 2022 Earnings Call Transcript
August 02, 2022
Tickers
SRPT
Tags
Market News
Recent Press Releases
SRPT
From
Motley Fool
Sarepta Therapeutics: Q2 Earnings Insights
August 02, 2022
Tickers
SRPT
Tags
BZI/Recaps
SRPT
Benzinga
From
Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
Tickers
ABBV
ACIU
ALLR
AXLA
Tags
Biotech
Benzinga
HALO
From
Benzinga
Earnings Scheduled For August 2, 2022
August 02, 2022
Tickers
LUNG
LXRX
MAR
MCHP
Tags
NMIH
SPGI
MTCH
From
Benzinga
Sarepta Therapeutics Earnings Preview
August 01, 2022
Tickers
SRPT
Tags
Market News
Benzinga
Earnings
From
Benzinga
Chevron, Amazon And Some Other Big Gainers From Friday
August 01, 2022
Tickers
AMTD
AMZN
AXTI
CROX
Tags
HAYN
GHM
AMZN
From
Benzinga
Recap Of Friday's Biotech Catalysts - End of The Day Summary
July 29, 2022
Tickers
ABBV
ADMP
ARQT
BMY
Tags
General
Small Cap
PFE
From
Benzinga
Duchenne Gene Therapy Firm Sarepta Therapeutics' Earns 8% Price Target Hike From This Analyst
July 29, 2022
Tickers
SRPT
Tags
News
Health Care
Trading Ideas
From
Benzinga
Why Sarepta Therapeutics Stock Is Perking Up Today
July 29, 2022
Tickers
SRPT
Tags
Recent Press Releases
Market News
SRPT
From
Motley Fool
Where Sarepta Therapeutics Stands With Analysts
July 29, 2022
Tickers
SRPT
Tags
Benzinga
Market News
BZI/AAR
From
Benzinga
Apple, Amazon And Some Other Big Stocks Recording Gains On Friday
July 29, 2022
Tickers
AMZN
AXTI
CVRX
CVX
Tags
INT
MITK
Penny Stocks
From
Benzinga
Exxon Mobil (XOM) Stock Pops on Record Profits
July 29, 2022
Tickers
CENN
HSY
SRPT
XOM
Tags
SRPT
NYSE:XOM,NYSE:HSY,NASDAQ:SRPT,NASDAQ:CENN
Market News
From
InvestorPlace
CENN Stock Alert: Cenntro Invests in E-Cargo Designer
July 29, 2022
Tickers
CENN
ROKU
SRPT
Tags
NASDAQ:CENN,NASDAQ:SRPT,NASDAQ:ROKU
Today's Market
SRPT
From
InvestorPlace
Sarepta Intents To Seek Accelerated Approval For Gene Therapy Candidate
July 29, 2022
Tickers
SRPT
Tags
General
SRPT
BLA Submission
From
Benzinga
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update
July 29, 2022
Tickers
ABBV
ADMP
ARQT
AZN
Tags
Financing
General
Small Cap
From
Benzinga
Sarepta (SRPT) Stock Gains on FDA News
July 29, 2022
Tickers
ROKU
SRPT
Tags
NASDAQ:SRPT,NASDAQ:ROKU
Market News
ROKU
From
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
July 20, 2022
Tickers
AZN
AZTA
BEAM
CTIC
Tags
BZI/AUOA
NTLA
Options
From
Benzinga
Avidity Biosciences Or Dyne Therapeutics - Read On Raymond James' Rating Skew
July 12, 2022
Tickers
DYN
RNA
SRPT
Tags
Health Care
News
Market News
From
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.